From Schedule I to Schedule III: The Path to Success?
In a significant development, the U.S. Department of Health and Human Services (HHS) officially recommended
Massachusetts Hits $5 Billion Marijuana Sales Milestone As State Sees Consecutive Record-Breaking Monthly Purchases
Massachusetts retailers have now sold more than $5 billion in adult-use marijuana since the state’s
High Times Unveils Deal with Nasdaq-Listed Lucy Scientific Discovery to Enter Public Market
Celebrating a milestone in its nearly 50-year history of informing readers and bringing cannabis culture
Medical Marijuana Patients See Improved Quality Of Life And Lower Pain, Anxiety And Depression After Three Months Of Use, Study Shows
Patients with chronic health conditions saw significant improvements in overall quality of life and reductions
Marijuana as Schedule III: Woe is Me?
By Hilary Bricken, Principal at Harris Bricken Unless you’ve been living under a rock, you
The Daily Hit: September 6, 2023
The Daily Hit is a recap of the top financial news stories for Sept. 6,
Third Minnesota Tribe to Enter Recreational Marijuana Market
A full-fledged market launch date for the state is still to be determined. The recreational
ESOPs provide a substantial and game changing edge for cannabis operators
By David McManus and Darren Gleeman Cannabis operators have plenty of challenges keeping pace with
Reset Pharma Licenses Filament Drug to Combat Demoralization in Cancer Patients
Reset Pharma is specifically honing in on the plight of cancer patients. Filament Health (OTCQB:
Maryland Marijuana Retailers Sell Record $92 Million In Products During State’s Second Month Of Adult-Use Legalization
Marijuana retailers in Maryland broke another record last month, selling nearly $92 million worth of